Overview

Evaluate the Efficacy and Safety of ACP-044 in Subjects With Pain Associated With Osteoarthritis of the Knee

Status:
Recruiting

Trial end date:
2023-01-01

Target enrollment:

Participant gender:

Summary

To evaluate the efficacy of ACP-044 compared with placebo in the treatment of pain associated with osteoarthritis of the knee

Phase:

Phase 2

Details

Lead Sponsor:

ACADIA Pharmaceuticals Inc.